FIRSTPOST YOUSPEAK
Saturday, May 18th 10:26 PM IST
Gallery
Food And Drug Administration GALLERY.
Indian employees of the Ranbaxy Laboratories Limited pharmaceutical Indian factory leave work at the end of the day at Toansa village in Ropar about 50 Km from Chandigarh on May 14, 2013. The US subsidiary of New Delhi-based Ranbaxy Laboratories pleaded guilty to seven counts of felony after it distributed several India-produced adulterated generic drugs in the United States in 2005 and 2006. They were all made in a facility near Chandigarh city in northern India, which US Food and Drug Administration inspectors cited for poor record keeping and inadequate testing for the stability of the drugs over time. Indian employees of the Ranbaxy Lab
A view of the Ranbaxy Laboratories Limited pharmaceutical Indian factory at Toansa village in Ropar about 50 Km from Chandigarh on May 14, 2013. The US subsidiary of New Delhi-based Ranbaxy Laboratories pleaded guilty to seven counts of felony after it distributed several India-produced adulterated generic drugs in the United States in 2005 and 2006. They were all made in a facility near Chandigarh city in northern India, which US Food and Drug Administration inspectors cited for poor record keeping and inadequate testing for the stability of the drugs over time. A view of the Ranbaxy Laboratories
Margaret Hamburg, Commissioner of the U.S. Food and Drug Administration (FDA), speaks during the 2013 Reuters Health Summit in New York, May 6, 2013. Margaret Hamburg, Commissioner of t
This product image provided by the Wm. Wrigley Jr. Company shows packaging for Alert Energy Caffeine Gum. Wrigley says it is taking a new caffeinated gum off the market temporarily as the Food and Drug Administration investigates the safety of added caffeine. The company said Wednesday, May 8, 2013, that it has stopped new sales and marketing of Alert Energy Caffeine Gum This product image provided by the
Importers and supporters offers samples of French cheese Mimolette to pedestrians during an event to support the import in the US of the 17th century-old cheese, after the US Food and Drug Administration (FDA) blocked the cheese to enter the territory, during an event in New York, April 13, 2013. The FDA, blocked the import of Mimolette on the ground that the cheese was infested with microscopic cheese mites on the surface, which can cause allergic reactions. Importers and supporters offers sam
Health and Human Services (HHS) Secretary Kathleen Sebelius, center, accompanied by Centers for Medicare and Medicaid Services Acting Administrator Marilyn Tavenner, left, and Food and Drug Administration (FDA) Commissioner Margaret Hamburg, speaks during a news conference at the HHS in Washington, Wednesday, April 10, 2013, to discuss President Barack Obama's fiscal 2014 for the Health Department. Health and Human Services (HHS) Sec
Food and Drug Administration (FDA) Commissioner Margaret Hamburg, second from left, with Health and Human Services Secretary Kathleen Sebelius, left, and others, speaks during a news conference at the Health and Humans Services (HHS) Department in Washington, Wednesday, April 10, 2013, to discuss the Health Department's fiscal 2014 budget. Food and Drug Administration (FDA)
FILE - In this Wednesday, April 10, 2013 file photo, Food and Drug Administration (FDA) Commissioner Margaret Hamburg, foreground, with Health and Human Services Secretary Kathleen Sebelius, left, and others, speaks during a news conference at the Health and Humans Services (HHS) Department in Washington, to discuss the Health Department's fiscal 2014 budget. The Food and Drug Administration says it has uncovered potential safety problems at 30 specialty pharmacies that were inspected in the wake of a recent outbreak of meningitis caused by contaminated drugs. In a blog post to the FDA's website Thursday, April 11, Hamburg noted that four pharmacies initially refused to admit the agency's inspectors. In two cases the agency had to return with search warrants and U.S. marshals to complete the inspections. FILE - In this Wednesday, April 10,
Protesters hold an eat-in in front of the U.S. Food and Drug Administration's Center for Food Safety and Applied Nutrition in College Park, Maryland April 8, 2013. The protesters are demanding for Genetically Modified Foods (GMO) to be labelled and tested long-term on human beings before being approved, as well as to invalidate the seed patents of Monsanto and other agritech companies. Protesters hold an eat-in in front
In this photo from video provided by Intuitive Surgical, Inc. of Sunnyvale, Calif., maker of the da Vinci robotic system, doctors are seen using the device to perform a surgery. Surgeons say the advantages of the system include allowing them to operate sitting down, using small robotic hands with no tremor. But critics say a big increase in robot operations nationwide is due to heavy marketing and hype, and the U.S. Food and Drug Administration is looking into problems and deaths that may be linked with robotic surgery. In this photo from video provided b
CHICAGO, IL - APRIL 05: This photo illustration shows a package of Plan B contraceptive on April 5, 2013 in Chicago, Illinois. A federal judge in New York City has ordered the Food and Drug Administration to make Plan B contraceptive, also known as the morning after pill, available to younger teens without a prescription within 30 days. The judge's ruling overturns a December 2011 decision by the FDA to restrict access to the contraceptive to any girl under 17 years of age. CHICAGO, IL - APRIL 05: This photo
A Plan B One-Step emergency contraceptive box is seen in New York, April 5, 2013. A federal judge on Friday ordered the U.S. Food and Drug Administration to make A Plan B One-Step emergency contrac
FILE - In this Oct. 16, 2012 file photo a Food and Drug Administration Agent stands at the doorway of New England Compounding Center in Framingham, Mass. Michigan's attorney general announced Tuesday, March 26, 2013 he is seeking a criminal investigation into the deaths of 17 residents from contaminated steroids supplied by a Massachusetts pharmaceutical company. He said Michigan leads the country in patients affected by the fungal meningitis outbreak. FILE - In this Oct. 16, 2012 file p
Food and Drug Administration special agent Robert Maes looks for gas tanks labels during a joint operation dubbed Food and Drug Administration specia
Agents with the Food and Drug Administration's Office of Criminal Investigations search for nitrous oxide tanks in the back of a warehouse during a joint operation dubbed Agents with the Food and Drug Admin
In this March 22, 2013 photo, Dr. Pier Giulianotti, chief of minimally invasive and robotic surgery at the University of Illinois Hospital & Health Sciences System in Chicago, shows off a robotic arm of the da Vinci robot system. Surgeons say the advantages of the system include allowing them to operate sitting down, using small robotic hands with no tremor. But critics say a big increase in robot operations nationwide is due to heavy marketing and hype, and the U.S. Food and Drug Administration is looking into problems and deaths that may be linked with robotic surgery. In this March 22, 2013 photo, Dr. P
Staff Scientist Ji Guo inspects test tubes containing dyes in a laboratory at the U.S. Food and Drug Administration (FDA) in Silver Spring, Maryland in this file photo from August 14, 2012. Picture taken August 14, 2012. The Food and Drug Administration announced a reduction of $133 million in non-user fee funding, causing Staff Scientist Ji Guo inspects tes
Staff Scientist Ji Guo inspects test tubes containing dyes in a laboratory at the U.S. Food and Drug Administration (FDA) in Silver Spring, Maryland in this August 14, 2012 file photo. Research and the fight against infectious diseases could be on the list of cutbacks as the White House warns of possible damage to public services, from less child care to air travel chaos, from the $85 billion across the board budget cuts that are due to begin March 1. Staff Scientist Ji Guo inspects tes
This undated image provided by Roche on Friday, Feb. 22, 2013 shows a vial and packaging for the drug Kadcyla. On Friday, Feb. 22, 2013, the U.S. Food and Drug Administration announced the approval of the first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones. This undated image provided by Roch
The The "Argus II implant" made by Seco
This undated product image provided by Second Sight Medical Products shows a new implantable device that takes the place of damaged cells inside the eye. The Food and Drug Administration on Thursday, Feb. 14, 2013, approved the Argus II Retinal Prosthesis System as the first treatment for an inherited disorder that causes the breakdown of cells in the retina, a membrane inside the eye. The FDA says that while the device will not fully restore patients' vision, This undated product image provided
U.S. Food and Drug Administration special agent Jeff Novitzky enters the U.S. Ninth Circuit Court of Appeals in San Francisco, California February 13, 2013. Attorneys for former MLB player Barry Bonds were in court to appeal his obstruction of justice conviction. Novitzky pursued Bonds in the BALCO steroids case. U.S. Food and Drug Administration s
This undated image made available by Teva Women's Health shows the packaging for their Plan B One-Step (levonorgestrel) tablet, one of the brands known as the This undated image made available b
The new long-acting insulin Tresiba drug is seen on a Novo Nordisk production line, in this 2012 handout picture provided by Novo Nordisk. U.S. regulators on February 10, 2013 dealt a major blow to Novo Nordisk's hopes for its new long-acting insulin Tresiba by demanding the Danish drugmaker conduct additional clinical tests to assess potential heart risks. Novo, the world's biggest insulin maker, said the U.S. Food and Drug Administration (FDA) had requested additional data from a dedicated cardiovascular outcomes trial before it would consider approving Tresiba and related product Ryzodeg. The drugmaker - which is banking on Tresiba to keep it in the lead in diabetes care - said on Sunday it would not be able to provide the data in 2013 or 2014. Analysts said the FDA's stance could delay Tresiba until 2015 or 2016. The new long-acting insulin Tresiba
Fisherman Pat Kehoe holds a paper mache Fisherman Pat Kehoe holds a paper m
About 130 people gather at Crescent Harbor in Sitka, Alaska, Saturday February 9, 2013, to demonstrate opposition to pending Food and Drug Administration approval of genetically modified salmon. Rally organizers encouraged people to send comments to the FDA before a February 25 deadline. About 130 people gather at Crescent
Bottles of adjuvants for use with the Pandemrix H1N1 flu vaccine are seen lined up during a vaccination programme in Schiedam in this November 23, 2009 file photo. Mounting evidence of a link between GlaxoSmithKline's Pandemrix flu shot and a spike in narcolepsy cases among children in Europe is putting one of the vaccine's key ingredients, AS03, under intense scrutiny. The ingredient is one of a class of pharmaceuticals known as adjuvants, or boosters, designed to turbo charge the potency of a vaccine and the body's immune response to it. AS03 was widely used in Europe during the 2009-2010 H1N1 flu pandemic and is also contained in a GSK adjuvanted flu vaccine which in November last year became the first of its kind to be recommended for approval by the normally adjuvant-wary United States Food and Drug Administration (FDA). To match Insight NARCOLEPSY-VACCINE/ADJUVANT. Bottles of adjuvants for use with t
This Nov. 27, 2012 file photo shows the Sunland Inc. peanut butter and nut processing plant in eastern New Mexico, near Portales, which has been shuttered since late September due to a salmonella outbreak that sickened dozens. The U.S. Food and Drug Administration on Friday proposed the most sweeping food safety rules in decades, requiring farmers and food companies to be more vigilant in the wake of deadly outbreaks in peanuts, cantaloupe and leafy greens. This Nov. 27, 2012 file photo shows
This Nov. 27, 2012 photo shows the Sunland Inc. peanut butter and nut processing plant in eastern New Mexico, near Portales, which has been shuttered since late September due to a salmonella outbreak that sickened dozens. The Food and Drug Administration on Monday, Nov. 26, 2012, suspended the registration of Sunland Inc., which is the country's largest organic peanut butter processor. FDA officials found salmonella in numerous locations in Sunland's processing plant after 41 people in 20 states, most of them children, were sickened by peanut butter manufactured at the Portales, N.M., plant and sold at the Trader Joe's grocery chain. The company had announced plans to reopen its peanut processing facility on Tuesday after voluntarily shutting down earlier this fall. This Nov. 27, 2012 photo shows the
NEW YORK, NY - NOVEMBER 15: The drink 5-Hour Energy is viewed for sale at a grocery store on November 15, 2012 in New York City. The federal government and the New York Attorney General's office have announced that they are investigating the popular energy drink after the Food and Drug Administration received claims that 5-Hour Energy has over the past four years led to 13 deaths and 33 hospitalizations. NEW YORK, NY - NOVEMBER 15: The dr